Global Valacyclovir API Market Research Report 2025

Publication ID:

PB501254454

Publication Date:

February 5, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Valaciclovir(CAS锛�124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Valacyclovir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir API.
The Valacyclovir API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Valacyclovir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan
NEWEDGE Overseas
Aurore Life Sciences
Arch Pharmalabs
SMS Pharmaceuticals
Exemed PharmaceuticalsFDAWHO-GMP
Aurobindo Pharma LimitedFDAEDQMWHO-GMP
Piramal Pharma Solutions
Rajasthan Antibiotics
Vital Laboratories Private Limited
by Type
Above 98 %
Above 99 %
by Application
Tablets
Others
Production by Region
North America
Europe
China
Australia
Israel
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Valacyclovir API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Valacyclovir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Valacyclovir API Market Overview
1.1 Product Definition
1.2 Valacyclovir API by Type
1.2.1 Global Valacyclovir API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Valacyclovir API by Application
1.3.1 Global Valacyclovir API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Valacyclovir API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Valacyclovir API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Valacyclovir API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Valacyclovir API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Valacyclovir API Production Market Share by Manufacturers (2020-2025)
2.2 Global Valacyclovir API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Valacyclovir API, Industry Ranking, 2023 VS 2024
2.4 Global Valacyclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Valacyclovir API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Valacyclovir API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Valacyclovir API, Product Offered and Application
2.8 Global Key Manufacturers of Valacyclovir API, Date of Enter into This Industry
2.9 Valacyclovir API Market Competitive Situation and Trends
2.9.1 Valacyclovir API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Valacyclovir API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Valacyclovir API Production by Region
3.1 Global Valacyclovir API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Valacyclovir API Production Value by Region (2020-2031)
3.2.1 Global Valacyclovir API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Valacyclovir API by Region (2026-2031)
3.3 Global Valacyclovir API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Valacyclovir API Production Volume by Region (2020-2031)
3.4.1 Global Valacyclovir API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Valacyclovir API by Region (2026-2031)
3.5 Global Valacyclovir API Market Price Analysis by Region (2020-2025)
3.6 Global Valacyclovir API Production and Value, Year-over-Year Growth
3.6.1 North America Valacyclovir API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Valacyclovir API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Valacyclovir API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Australia Valacyclovir API Production Value Estimates and Forecasts (2020-2031)
3.6.5 Israel Valacyclovir API Production Value Estimates and Forecasts (2020-2031)
4 Valacyclovir API Consumption by Region
4.1 Global Valacyclovir API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Valacyclovir API Consumption by Region (2020-2031)
4.2.1 Global Valacyclovir API Consumption by Region (2020-2025)
4.2.2 Global Valacyclovir API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Valacyclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Valacyclovir API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Valacyclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Valacyclovir API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Valacyclovir API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Valacyclovir API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Valacyclovir API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Valacyclovir API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Valacyclovir API Production by Type (2020-2031)
5.1.1 Global Valacyclovir API Production by Type (2020-2025)
5.1.2 Global Valacyclovir API Production by Type (2026-2031)
5.1.3 Global Valacyclovir API Production Market Share by Type (2020-2031)
5.2 Global Valacyclovir API Production Value by Type (2020-2031)
5.2.1 Global Valacyclovir API Production Value by Type (2020-2025)
5.2.2 Global Valacyclovir API Production Value by Type (2026-2031)
5.2.3 Global Valacyclovir API Production Value Market Share by Type (2020-2031)
5.3 Global Valacyclovir API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Valacyclovir API Production by Application (2020-2031)
6.1.1 Global Valacyclovir API Production by Application (2020-2025)
6.1.2 Global Valacyclovir API Production by Application (2026-2031)
6.1.3 Global Valacyclovir API Production Market Share by Application (2020-2031)
6.2 Global Valacyclovir API Production Value by Application (2020-2031)
6.2.1 Global Valacyclovir API Production Value by Application (2020-2025)
6.2.2 Global Valacyclovir API Production Value by Application (2026-2031)
6.2.3 Global Valacyclovir API Production Value Market Share by Application (2020-2031)
6.3 Global Valacyclovir API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Valacyclovir API Company Information
7.1.2 Mylan Valacyclovir API Product Portfolio
7.1.3 Mylan Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 NEWEDGE Overseas
7.2.1 NEWEDGE Overseas Valacyclovir API Company Information
7.2.2 NEWEDGE Overseas Valacyclovir API Product Portfolio
7.2.3 NEWEDGE Overseas Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 NEWEDGE Overseas Main Business and Markets Served
7.2.5 NEWEDGE Overseas Recent Developments/Updates
7.3 Aurore Life Sciences
7.3.1 Aurore Life Sciences Valacyclovir API Company Information
7.3.2 Aurore Life Sciences Valacyclovir API Product Portfolio
7.3.3 Aurore Life Sciences Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Aurore Life Sciences Main Business and Markets Served
7.3.5 Aurore Life Sciences Recent Developments/Updates
7.4 Arch Pharmalabs
7.4.1 Arch Pharmalabs Valacyclovir API Company Information
7.4.2 Arch Pharmalabs Valacyclovir API Product Portfolio
7.4.3 Arch Pharmalabs Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Arch Pharmalabs Main Business and Markets Served
7.4.5 Arch Pharmalabs Recent Developments/Updates
7.5 SMS Pharmaceuticals
7.5.1 SMS Pharmaceuticals Valacyclovir API Company Information
7.5.2 SMS Pharmaceuticals Valacyclovir API Product Portfolio
7.5.3 SMS Pharmaceuticals Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 SMS Pharmaceuticals Main Business and Markets Served
7.5.5 SMS Pharmaceuticals Recent Developments/Updates
7.6 Exemed PharmaceuticalsFDAWHO-GMP
7.6.1 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Company Information
7.6.2 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product Portfolio
7.6.3 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Exemed PharmaceuticalsFDAWHO-GMP Main Business and Markets Served
7.6.5 Exemed PharmaceuticalsFDAWHO-GMP Recent Developments/Updates
7.7 Aurobindo Pharma LimitedFDAEDQMWHO-GMP
7.7.1 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Company Information
7.7.2 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product Portfolio
7.7.3 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Main Business and Markets Served
7.7.5 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Developments/Updates
7.8 Piramal Pharma Solutions
7.8.1 Piramal Pharma Solutions Valacyclovir API Company Information
7.8.2 Piramal Pharma Solutions Valacyclovir API Product Portfolio
7.8.3 Piramal Pharma Solutions Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Piramal Pharma Solutions Main Business and Markets Served
7.8.5 Piramal Pharma Solutions Recent Developments/Updates
7.9 Rajasthan Antibiotics
7.9.1 Rajasthan Antibiotics Valacyclovir API Company Information
7.9.2 Rajasthan Antibiotics Valacyclovir API Product Portfolio
7.9.3 Rajasthan Antibiotics Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Rajasthan Antibiotics Main Business and Markets Served
7.9.5 Rajasthan Antibiotics Recent Developments/Updates
7.10 Vital Laboratories Private Limited
7.10.1 Vital Laboratories Private Limited Valacyclovir API Company Information
7.10.2 Vital Laboratories Private Limited Valacyclovir API Product Portfolio
7.10.3 Vital Laboratories Private Limited Valacyclovir API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Vital Laboratories Private Limited Main Business and Markets Served
7.10.5 Vital Laboratories Private Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Valacyclovir API Industry Chain Analysis
8.2 Valacyclovir API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Valacyclovir API Production Mode & Process Analysis
8.4 Valacyclovir API Sales and Marketing
8.4.1 Valacyclovir API Sales Channels
8.4.2 Valacyclovir API Distributors
8.5 Valacyclovir API Customer Analysis
9 Valacyclovir API Market Dynamics
9.1 Valacyclovir API Industry Trends
9.2 Valacyclovir API Market Drivers
9.3 Valacyclovir API Market Challenges
9.4 Valacyclovir API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Mylan
NEWEDGE Overseas
Aurore Life Sciences
Arch Pharmalabs
SMS Pharmaceuticals
Exemed PharmaceuticalsFDAWHO-GMP
Aurobindo Pharma LimitedFDAEDQMWHO-GMP
Piramal Pharma Solutions
Rajasthan Antibiotics
Vital Laboratories Private Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂